Terms: = Bone cancer AND CCDC6, D10S170, 8030, ENSG00000108091, Q16204, TPC, H4, TST1 AND Treatment
21 results:
1. OHCCPredictor: an online risk stratification model for predicting survival duration of older patients with hepatocellular carcinoma.
Tan J; Yu Y; Lin X; He Y; Jin W; Qian H; Li Y; Xu X; Zhao Y; Ning J; Zhang Z; Chen J; Wu X
Hepatol Int; 2024 Apr; 18(2):550-567. PubMed ID: 37067674
[TBL] [Abstract] [Full Text] [Related]
2. Differential Histone Posttranslational Modifications Induced by DNA Hypomethylating Agents.
Malkaram SA; Shatnawi A; Fan J; Carraway H; Denvir J; Primerano DA; Abd Elmageed ZY; Fandy TE
Cancer Control; 2022; 29():10732748221074051. PubMed ID: 35067084
[TBL] [Abstract] [Full Text] [Related]
3. Targeting the methyltransferase SETD8 impairs tumor cell survival and overcomes drug resistance independently of p53 status in multiple myeloma.
Herviou L; Ovejero S; Izard F; Karmous-Gadacha O; Gourzones C; Bellanger C; De Smedt E; Ma A; Vincent L; Cartron G; Jin J; De Bruyne E; Grimaud C; Julien E; Moreaux J
Clin Epigenetics; 2021 Sep; 13(1):174. PubMed ID: 34530900
[TBL] [Abstract] [Full Text] [Related]
4. Ultrasound May Suppress Tumor Growth, Inhibit Inflammation, and Establish Tolerogenesis by Remodeling Innatome via Pathways of ROS, Immune Checkpoints, Cytokines, and Trained Immunity/Tolerance.
Yang Q; Zhang R; Tang P; Sun Y; Johnson C; Saredy J; Wu S; Wang J; Lu Y; Saaoud F; Shao Y; Drummer C; Xu K; Yu D; Li R; Ge S; Jiang X; Wang H; Yang X
J Immunol Res; 2021; 2021():6664453. PubMed ID: 33628851
[TBL] [Abstract] [Full Text] [Related]
5. Healthcare resource utilization and associated cost of patients with bone metastases from solid tumors who are naïve to bone-targeting agents: a comparative analysis of patients with and without skeletal-related events.
Hardtstock F; Kocaata Z; Wilke T; Dittmar A; Ghiani M; Belozeroff V; Harrison DJ; Maywald U; Tesch H
Eur J Health Econ; 2021 Mar; 22(2):243-254. PubMed ID: 33459901
[TBL] [Abstract] [Full Text] [Related]
6. Mesenchymal stem cells-originated exosomal microRNA-152 impairs proliferation, invasion and migration of thyroid carcinoma cells by interacting with DPP4.
Tang M; Wang Q; Wang K; Wang F
J Endocrinol Invest; 2020 Dec; 43(12):1787-1796. PubMed ID: 32876927
[TBL] [Abstract] [Full Text] [Related]
7. Predictive value of neuron-specific enolase, neutrophil-to-lymphocyte-ratio and lymph node metastasis for distant metastasis in small cell lung cancer.
Xia X; Li K; Wu R; Lv Q; Deng X; Fei Z; Zou C; Yang X
Clin Respir J; 2020 Nov; 14(11):1060-1066. PubMed ID: 32750207
[TBL] [Abstract] [Full Text] [Related]
8. Distinct tumor microenvironments of lytic and blastic bone metastases in prostate cancer patients.
Ihle CL; Provera MD; Straign DM; Smith EE; Edgerton SM; Van Bokhoven A; Lucia MS; Owens P
J Immunother Cancer; 2019 Nov; 7(1):293. PubMed ID: 31703602
[TBL] [Abstract] [Full Text] [Related]
9. Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial.
Twelves C; Cortés J; O'Shaughnessy J; Awada A; Perez EA; Im SA; Gómez-Pardo P; Schwartzberg LS; Diéras V; Yardley DA; Potter DA; Mailliez A; Moreno-Aspitia A; Ahn JS; Zhao C; Hoch U; Tagliaferri M; Hannah AL; Rugo HS
Eur J Cancer; 2017 May; 76():205-215. PubMed ID: 28360015
[TBL] [Abstract] [Full Text] [Related]
10. RET Fusion Lung Carcinoma: Response to Therapy and Clinical Features in a Case Series of 14 Patients.
Sarfaty M; Moore A; Neiman V; Dudnik E; Ilouze M; Gottfried M; Katznelson R; Nechushtan H; Sorotsky HG; Paz K; Katz A; Saute M; Wolner M; Moskovitz M; Miller V; Elvin J; Lipson D; Ali S; Gutman LS; Dvir A; Gordon N; Peled N
Clin Lung Cancer; 2017 Jul; 18(4):e223-e232. PubMed ID: 28082048
[TBL] [Abstract] [Full Text] [Related]
11. Preserved global histone H4 acetylation linked to ETV6-RUNX1 fusion and PAX5 deletions is associated with favorable outcome in pediatric B-cell progenitor acute lymphoblastic leukemia.
Janczar K; Janczar S; Pastorczak A; Mycko K; Paige AJ; Zalewska-Szewczyk B; Wagrowska-Danilewicz M; Danilewicz M; Mlynarski W
Leuk Res; 2015 Dec; 39(12):1455-61. PubMed ID: 26520622
[TBL] [Abstract] [Full Text] [Related]
12. Protection of radiation-induced damage to the hematopoietic system, small intestine and salivary glands in rats by JNJ7777120 compound, a histamine H4 ligand.
Martinel Lamas DJ; Carabajal E; Prestifilippo JP; Rossi L; Elverdin JC; Merani S; Bergoc RM; Rivera ES; Medina VA
PLoS One; 2013; 8(7):e69106. PubMed ID: 23922686
[TBL] [Abstract] [Full Text] [Related]
13. Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients.
Advani AS; Gibson SE; Douglas E; Jin T; Zhao X; Kalaycio M; Copelan E; Sobecks R; Sekeres M; Sungren S; Hsi ED
BMC Cancer; 2010 Jul; 10():387. PubMed ID: 20663136
[TBL] [Abstract] [Full Text] [Related]
14. Histone deacetylase inhibitors decrease proliferation potential and multilineage differentiation capability of human mesenchymal stem cells.
Lee S; Park JR; Seo MS; Roh KH; Park SB; Hwang JW; Sun B; Seo K; Lee YS; Kang SK; Jung JW; Kang KS
Cell Prolif; 2009 Dec; 42(6):711-20. PubMed ID: 19689470
[TBL] [Abstract] [Full Text] [Related]
15. Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies.
Fandy TE; Herman JG; Kerns P; Jiemjit A; Sugar EA; Choi SH; Yang AS; Aucott T; Dauses T; Odchimar-Reissig R; Licht J; McConnell MJ; Nasrallah C; Kim MK; Zhang W; Sun Y; Murgo A; Espinoza-Delgado I; Oteiza K; Owoeye I; Silverman LR; Gore SD; Carraway HE
Blood; 2009 Sep; 114(13):2764-73. PubMed ID: 19546476
[TBL] [Abstract] [Full Text] [Related]
16. BMP4-Smad signaling pathway mediates adriamycin-induced premature senescence in lung cancer cells.
Su D; Zhu S; Han X; Feng Y; Huang H; Ren G; Pan L; Zhang Y; Lu J; Huang B
J Biol Chem; 2009 May; 284(18):12153-64. PubMed ID: 19269967
[TBL] [Abstract] [Full Text] [Related]
17. Boric acid inhibits embryonic histone deacetylases: a suggested mechanism to explain boric acid-related teratogenicity.
Di Renzo F; Cappelletti G; Broccia ML; Giavini E; Menegola E
Toxicol Appl Pharmacol; 2007 Apr; 220(2):178-85. PubMed ID: 17320131
[TBL] [Abstract] [Full Text] [Related]
18. Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias.
Gojo I; Jiemjit A; Trepel JB; Sparreboom A; Figg WD; Rollins S; Tidwell ML; Greer J; Chung EJ; Lee MJ; Gore SD; Sausville EA; Zwiebel J; Karp JE
Blood; 2007 Apr; 109(7):2781-90. PubMed ID: 17179232
[TBL] [Abstract] [Full Text] [Related]
19. Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia.
Cimino G; Lo-Coco F; Fenu S; Travaglini L; Finolezzi E; Mancini M; Nanni M; Careddu A; Fazi F; Padula F; Fiorini R; Spiriti MA; Petti MC; Venditti A; Amadori S; Mandelli F; Pelicci PG; Nervi C
Cancer Res; 2006 Sep; 66(17):8903-11. PubMed ID: 16951208
[TBL] [Abstract] [Full Text] [Related]
20. Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells.
De Felice L; Tatarelli C; Mascolo MG; Gregorj C; Agostini F; Fiorini R; Gelmetti V; Pascale S; Padula F; Petrucci MT; Arcese W; Nervi C
Cancer Res; 2005 Feb; 65(4):1505-13. PubMed ID: 15735039
[TBL] [Abstract] [Full Text] [Related]
[Next]
